Just saw that Wolfe Research slapped a 'Peer Perform' rating on $O, which is basically saying it's not going anywhere special compared to its peers. Interesting timing though, because the broader analyst consensus seems a bit more bullish - we've got 3 buy ratings out there versus zero sells.

Looking at the price targets, analysts are clustering around $60.50 as the median. UBS is the most optimistic at $62, while a few others like Scotiabank and Barclays are sitting at $58. Stifel's pushing higher at $68, so there's definitely some disagreement on where this thing heads. Most of these targets came in over the past few months, so they're fairly recent.

What's interesting is the institutional money flow. Bank of America and JPMorgan both added massive positions in Q1 - we're talking hundreds of millions in value. Vanguard also increased their stake. But Parnassus and Cohen & Steers trimmed their holdings, so it's not a total consensus among the big money either.

Congress has been selling though - two reps offloaded shares in the past six months, no buys. Combined with that 'Peer Perform' call, it feels like the stock is caught between bullish analyst targets and some mixed signals from insiders and institutional rebalancing. Worth watching how this plays out over the next quarter.